Open AccessThe Evolving Landscape of JAK Inhibition in the Treatment of Myelofibrosis
Author(s) -
Prithviraj Bose,
Srđan Verstovšek
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000653328.50254.c2
Subject(s) - ruxolitinib , myelofibrosis , medicine , anemia , discontinuation , adverse effect , bone marrow